让医疗团队参与进来,增加阿片类药物使用障碍的药物获取途径。

IF 3.1 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES
Rebecca S. Oberman MSW, MPH, Alexis K. Huynh PhD, MPH, Kelsey Cummings MS, Adam Resnick PhD, Stephanie L. Taylor PhD, Alicia A. Bergman PhD, Evelyn T. Chang MD, MSHS
{"title":"让医疗团队参与进来,增加阿片类药物使用障碍的药物获取途径。","authors":"Rebecca S. Oberman MSW, MPH,&nbsp;Alexis K. Huynh PhD, MPH,&nbsp;Kelsey Cummings MS,&nbsp;Adam Resnick PhD,&nbsp;Stephanie L. Taylor PhD,&nbsp;Alicia A. Bergman PhD,&nbsp;Evelyn T. Chang MD, MSHS","doi":"10.1111/1475-6773.14371","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objective</h3>\n \n <p>To assess the effectiveness of evidence-based quality improvement (EBQI) as an implementation strategy to expand the use of medications for opioid use disorder (MOUD) within nonspecialty settings.</p>\n </section>\n \n <section>\n \n <h3> Data Sources and Study Setting</h3>\n \n <p>We studied eight facilities in one Veteran Health Administration (VHA) region from October 2015 to September 2022 using administrative data.</p>\n </section>\n \n <section>\n \n <h3> Study Design</h3>\n \n <p>Initially a pilot, we sequentially engaged seven of eight facilities from April 2018 to September 2022 using EBQI, consisting of multilevel stakeholder engagement, technical support, practice facilitation, and data feedback. We established facility-level interdisciplinary quality improvement (QI) teams and a regional-level cross-facility collaborative. We used a nonrandomized stepped wedge design with repeated cross sections to accommodate the phased implementation. Using aggregate facility-level data from October 2015 to September 2022, we analyzed changes in patients receiving MOUD using hierarchical multiple logistic regression.</p>\n </section>\n \n <section>\n \n <h3> Data Collection/Extraction Methods</h3>\n \n <p>Eligible patients had an opioid use disorder (OUD) diagnosis from an outpatient or inpatient visit in the previous year. Receiving MOUD was defined as having been prescribed an opioid agonist or antagonist treatment or a visit to an opioid substitution clinic.</p>\n </section>\n \n <section>\n \n <h3> Principal Findings</h3>\n \n <p>The probability of patients with OUD receiving MOUD improved significantly over time for all eight facilities (average marginal effect [AME]: 0.0057, 95% CI: 0.0044, 0.0070) due to ongoing VHA initiatives, with the probability of receiving MOUD increasing by 0.577 percentage points, on average, each quarter, totaling 16 percentage points during the evaluation period. The seven facilities engaging in EBQI experienced, on average, an additional 5.25 percentage point increase in the probability of receiving MOUD (AME: 0.0525, 95%CI: 0.0280, 0.0769). EBQI duration was not associated with changes.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>EBQI was effective for expanding access to MOUD in nonspecialty settings, resulting in increases in patients receiving MOUD exceeding those associated with temporal trends. Additional research is needed due to recent MOUD expansion legislation.</p>\n </section>\n </div>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":"59 S2","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2024-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11540584/pdf/","citationCount":"0","resultStr":"{\"title\":\"Engaging healthcare teams to increase access to medications for opioid use disorder\",\"authors\":\"Rebecca S. Oberman MSW, MPH,&nbsp;Alexis K. Huynh PhD, MPH,&nbsp;Kelsey Cummings MS,&nbsp;Adam Resnick PhD,&nbsp;Stephanie L. Taylor PhD,&nbsp;Alicia A. Bergman PhD,&nbsp;Evelyn T. Chang MD, MSHS\",\"doi\":\"10.1111/1475-6773.14371\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Objective</h3>\\n \\n <p>To assess the effectiveness of evidence-based quality improvement (EBQI) as an implementation strategy to expand the use of medications for opioid use disorder (MOUD) within nonspecialty settings.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Data Sources and Study Setting</h3>\\n \\n <p>We studied eight facilities in one Veteran Health Administration (VHA) region from October 2015 to September 2022 using administrative data.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Study Design</h3>\\n \\n <p>Initially a pilot, we sequentially engaged seven of eight facilities from April 2018 to September 2022 using EBQI, consisting of multilevel stakeholder engagement, technical support, practice facilitation, and data feedback. We established facility-level interdisciplinary quality improvement (QI) teams and a regional-level cross-facility collaborative. We used a nonrandomized stepped wedge design with repeated cross sections to accommodate the phased implementation. Using aggregate facility-level data from October 2015 to September 2022, we analyzed changes in patients receiving MOUD using hierarchical multiple logistic regression.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Data Collection/Extraction Methods</h3>\\n \\n <p>Eligible patients had an opioid use disorder (OUD) diagnosis from an outpatient or inpatient visit in the previous year. Receiving MOUD was defined as having been prescribed an opioid agonist or antagonist treatment or a visit to an opioid substitution clinic.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Principal Findings</h3>\\n \\n <p>The probability of patients with OUD receiving MOUD improved significantly over time for all eight facilities (average marginal effect [AME]: 0.0057, 95% CI: 0.0044, 0.0070) due to ongoing VHA initiatives, with the probability of receiving MOUD increasing by 0.577 percentage points, on average, each quarter, totaling 16 percentage points during the evaluation period. The seven facilities engaging in EBQI experienced, on average, an additional 5.25 percentage point increase in the probability of receiving MOUD (AME: 0.0525, 95%CI: 0.0280, 0.0769). EBQI duration was not associated with changes.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>EBQI was effective for expanding access to MOUD in nonspecialty settings, resulting in increases in patients receiving MOUD exceeding those associated with temporal trends. Additional research is needed due to recent MOUD expansion legislation.</p>\\n </section>\\n </div>\",\"PeriodicalId\":55065,\"journal\":{\"name\":\"Health Services Research\",\"volume\":\"59 S2\",\"pages\":\"\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2024-09-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11540584/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Health Services Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/1475-6773.14371\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Services Research","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/1475-6773.14371","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

目的:评估循证质量改进(EBQI)作为在非专科环境中扩大阿片类药物使用障碍(MOUD)用药的实施策略的有效性:评估循证质量改进(EBQI)作为一种实施策略,在非专科环境中扩大阿片类药物使用障碍(MOUD)药物使用的有效性:从 2015 年 10 月到 2022 年 9 月,我们使用行政数据对退伍军人健康管理局(VHA)地区的八个机构进行了研究:研究设计:最初是一个试点,从 2018 年 4 月到 2022 年 9 月,我们使用 EBQI 依次参与了八家机构中的七家,包括多层次利益相关者参与、技术支持、实践促进和数据反馈。我们建立了设施级跨学科质量改进(QI)团队和地区级跨设施协作。我们采用了非随机阶梯式楔形设计,重复交叉部分以适应分阶段实施。利用 2015 年 10 月至 2022 年 9 月的机构级汇总数据,我们使用分层多元逻辑回归分析了接受 MOUD 的患者的变化情况:符合条件的患者在上一年的门诊或住院就诊中被诊断为阿片类药物使用障碍(OUD)。接受阿片类药物使用障碍治疗的定义是接受阿片类药物激动剂或拮抗剂治疗,或到阿片类药物替代诊所就诊:由于美国退伍军人事务部(VHA)的持续举措,随着时间的推移,所有八家机构的 OUD 患者接受 MOUD 治疗的概率都有了显著提高(平均边际效应 [AME]:0.0057,95% CI:0.0044, 0.0070),接受 MOUD 治疗的概率平均每季度提高 0.577 个百分点,在评估期间共提高了 16 个百分点。参与 EBQI 的七家医疗机构获得 MOUD 的概率平均增加了 5.25 个百分点(AME:0.0525,95%CI:0.0280,0.0769)。EBQI持续时间与变化无关:结论:EBQI能有效扩大非专科环境中的钼靶治疗机会,使接受钼靶治疗的患者人数增加,超过了与时间趋势相关的人数。由于最近扩大了MOUD的立法范围,因此还需要进行更多的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Engaging healthcare teams to increase access to medications for opioid use disorder

Engaging healthcare teams to increase access to medications for opioid use disorder

Objective

To assess the effectiveness of evidence-based quality improvement (EBQI) as an implementation strategy to expand the use of medications for opioid use disorder (MOUD) within nonspecialty settings.

Data Sources and Study Setting

We studied eight facilities in one Veteran Health Administration (VHA) region from October 2015 to September 2022 using administrative data.

Study Design

Initially a pilot, we sequentially engaged seven of eight facilities from April 2018 to September 2022 using EBQI, consisting of multilevel stakeholder engagement, technical support, practice facilitation, and data feedback. We established facility-level interdisciplinary quality improvement (QI) teams and a regional-level cross-facility collaborative. We used a nonrandomized stepped wedge design with repeated cross sections to accommodate the phased implementation. Using aggregate facility-level data from October 2015 to September 2022, we analyzed changes in patients receiving MOUD using hierarchical multiple logistic regression.

Data Collection/Extraction Methods

Eligible patients had an opioid use disorder (OUD) diagnosis from an outpatient or inpatient visit in the previous year. Receiving MOUD was defined as having been prescribed an opioid agonist or antagonist treatment or a visit to an opioid substitution clinic.

Principal Findings

The probability of patients with OUD receiving MOUD improved significantly over time for all eight facilities (average marginal effect [AME]: 0.0057, 95% CI: 0.0044, 0.0070) due to ongoing VHA initiatives, with the probability of receiving MOUD increasing by 0.577 percentage points, on average, each quarter, totaling 16 percentage points during the evaluation period. The seven facilities engaging in EBQI experienced, on average, an additional 5.25 percentage point increase in the probability of receiving MOUD (AME: 0.0525, 95%CI: 0.0280, 0.0769). EBQI duration was not associated with changes.

Conclusions

EBQI was effective for expanding access to MOUD in nonspecialty settings, resulting in increases in patients receiving MOUD exceeding those associated with temporal trends. Additional research is needed due to recent MOUD expansion legislation.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Health Services Research
Health Services Research 医学-卫生保健
CiteScore
4.80
自引率
5.90%
发文量
193
审稿时长
4-8 weeks
期刊介绍: Health Services Research (HSR) is a peer-reviewed scholarly journal that provides researchers and public and private policymakers with the latest research findings, methods, and concepts related to the financing, organization, delivery, evaluation, and outcomes of health services. Rated as one of the top journals in the fields of health policy and services and health care administration, HSR publishes outstanding articles reporting the findings of original investigations that expand knowledge and understanding of the wide-ranging field of health care and that will help to improve the health of individuals and communities.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信